Stanford Medicine Alumni Day 2026 Dean's Remarks - Dean Lloyd B. Minor, MD

Why It Matters

These announcements position Stanford Medicine at the forefront of oncology, AI integration, and affordable advanced therapies, shaping future research, clinical care, and industry partnerships.

Key Takeaways

• Dean Minor announced senior associate dean for basic science role
• New radiology chair and phase‑one trial leaders boost cancer focus
• AI curriculum and public resources aim for responsible medical adoption
• First‑of‑its‑kind $40M proton therapy lowers cost, expands access
• Redwood City cancer hospital land secured, entitlements under discussion

Summary

Dean Lloyd B. Minor opened Stanford Medicine Alumni Day by thanking alumni leaders and highlighting recent faculty appointments. He introduced Dan Yosh as the inaugural senior associate dean for basic science, welcomed Dr. Umar Mammud as chair of radiology, and announced Dr. V.C. Subbaya and Dr. Pamela Munster to lead a national phase‑one cancer trial network, underscoring Stanford’s strategic expansion in oncology.

The dean then spotlighted several research breakthroughs: safer, shorter conditioning regimens for stem‑cell transplants; vaccines that activate innate immunity for broader protection; and a neonatal‑ICU predictive model built on large‑language‑model algorithms. He also promoted the latest Stanford Medicine Magazine issue, which showcases the institution’s impact on health and society.

A major portion of the remarks focused on technology. Minor detailed Stanford’s AI education initiative, offering publicly available lectures on prompt engineering, hallucination detection, and clinical integration. He announced the third annual RAISE Health symposium, a week‑long series on responsible AI in healthcare, and highlighted a Stanford‑led genome‑scale language model that extends AlphaFold‑style insights to DNA.

Finally, Minor unveiled two infrastructure milestones: a $40 million compact proton‑therapy system that democratizes particle therapy, and the acquisition of land in Redwood City for a new cancer hospital and research campus. Both projects reinforce Stanford’s long‑standing reputation for radiation‑oncology innovation and its broader vision of a unified, AI‑enabled cancer ecosystem.

Original Description

Lloyd B. Minor, MD

Carl and Elizabeth Naumann Dean of the School of Medicine

Vice President for Medical Affairs at Stanford University

Dean Minor is a scientist, surgeon, and academic leader. He has served as dean of the Stanford University School of Medicine since December 2012. In addition, he is a professor of otolaryngology–head and neck surgery and, by courtesy, of neurobiology and bioengineering at Stanford University. As dean, Dr. Minor plays an integral role in setting strategy for the clinical enterprise of Stanford Medicine. He also oversees the quality of Stanford Medicine’s physician practices and growing clinical networks. With Dr. Minor’s leadership, Stanford Medicine has established a strategic vision to lead the biomedical revolution in precision health.

Part of Stanford Medicine Alumni Day 2026.